Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Raffles Medical GroupRAFLF 57 Equity-to-Asset is 0.75 as of Jun. 2026, which is 10% above its 10-year median of 0.68. GuruFocus rates RAFLF with a GF Score™ of 57/100 and a GF Value™ of $0.81 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Raffles Medical Group ranks better than 80.38% on this metric.
The historical rank and industry rank for Raffles Medical Group's Equity-to-Asset or its related term are showing as below:
RAFLF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.62 Med: 0.68 Max: 0.75
Current: 0.75
During the past 13 years, the highest Equity to Asset Ratio of Raffles Medical Group was 0.75. The lowest was 0.62. And the median was 0.68.
RAFLF's Equity-to-Asset is ranked better than 80.38% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 0.49
vs RAFLF: 0.75
Raffles Medical Group (OTCPK:RAFLF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Raffles Medical Group Equity-to-Asset Related Terms
Raffles Medical Group Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Raffles Medical Group's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RAFLF vs HCA, THC, EHC: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Raffles Medical Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raffles Medical Group Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Raffles Medical Group's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Raffles Medical Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raffles Medical Group (RAFLF) has a Equity-to-Asset of 0.75 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Raffles Medical Group and its competitors. This is 10% above median its historical median of 0.68. Over the past decade, Raffles Medical Group's Equity-to-Asset has ranged from 0.62 to 0.75. According to the industry distribution chart, Raffles Medical Group ranks #134 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 19.6%.
Is Raffles Medical Group's Equity-to-Asset too high?
Raffles Medical Group's current Equity-to-Asset of 0.75 is 10% above median its 10-year median of 0.68. Over the past 10 years, this metric has ranged from a low of 0.62 to a high of 0.75. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. Raffles Medical Group's value of 0.75 is 53.1% above this industry median. Based on the distribution chart, Raffles Medical Group ranks #134 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Raffles Medical Group has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #134 out of 683 companies for Equity-to-Asset. This places Raffles Medical Group in the top 20% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.49. Raffles Medical Group's value of 0.75 is 53.1% above this benchmark. Historically, Raffles Medical Group's own Equity-to-Asset has ranged from 0.62 to 0.75 over the past decade. While the company's 10-year median is 0.68 vs. the industry median of 0.49, Raffles Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raffles Medical Group's current Equity-to-Asset of 0.75 is 53.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Raffles Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raffles Medical Group's current Equity-to-Asset is 0.75, which is 10% above median its own 10-year median of 0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (RAFLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.81, compared to a current price of $0.67 — trading 17.3% below its estimated fair value. The current Equity-to-Asset is 0.75, which is 10% above median its 10-year median of 0.68 and 53.1% above the Healthcare Providers & Services industry median of 0.49. Raffles Medical Group's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Raffles Medical Group (RAFLF), the current Equity-to-Asset is 0.75 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raffles Medical Group (RAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Raffles Medical Group stock appears to be undervalued.
The current stock price of $0.67 is trading 17.3% below its estimated GF Value™ of $0.81.
GuruFocus considers Raffles Medical Group to be Modestly Undervalued.
Key valuation signals for RAFLF:
Equity-to-Asset: 0.75 (10% above median its 10-year median of 0.68)
GF Value™: $0.81 vs. price of $0.67 (17.3% below fair value)
Industry Position: 53.1% above the Healthcare Providers & Services median (#134 of 683)
No single metric tells the full story. See the RAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
57GF Score
Get the complete analysis for RAFLF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RAFLF has been successfully added to your 
